ArticleEuropean journal of breast health2026

Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study.

Rita Quaresma Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.